Invesco India Small Cap Fund Direct Growth NAV increased 0.20% to ₹54.34 on 22 September 2026, with fund assets of approximately ₹15,744 crore.

Key Takeaways:

• Invesco India Small Cap Fund Direct Growth NAV rose 0.20% to ₹54.34 on 22 September 2026, compared with approximately ₹54.23 on the preceding valuation date. 
• The scheme managed approximately ₹15,744 crore, with a Direct Growth expense ratio of 0.63% and both SIP and lump-sum investments starting at ₹100. 
• Sai Life Sciences was the largest listed equity position among the recent leading holdings at 4.94%, followed by Eternal, Krishna Institute of Medical Sciences and Aditya Infotech. 
• Net current assets represented 5.14% in the snapshot and should be separated from listed stocks when discussing the fund's equity concentration. 

Invesco India Small Cap Fund Direct Growth increased 0.20% to ₹54.34 on 22 September 2026. The previous valuation stood around ₹54.23, making the latest increase a moderate daily movement rather than a sharp change. 

The scheme managed approximately ₹15,744 crore. Its Direct Growth expense ratio was 0.63%, and both minimum SIP and minimum lump-sum investments stood at ₹100. The scheme has an operating history long enough for established multi-year trailing return periods to be assessed. 

Recent portfolio information listed net current assets at 5.14%, followed by Sai Life Sciences at 4.94%, Eternal at 4.62%, Krishna Institute of Medical Sciences at 4.10% and Aditya Infotech at 3.91%. Those five entries together represented 22.71% of the portfolio snapshot. 

Net current assets are not an equity security. Sai Life Sciences was therefore the largest listed equity position among those disclosed holdings. This distinction matters when describing portfolio concentration because cash-related or current-asset components should not be labelled as stocks. 

As a small-cap scheme, the fund invests predominantly in companies outside India's large- and mid-cap classifications. The mandate creates a different underlying exposure profile from large-cap and flexi-cap portfolios. 

The 0.20% NAV rise represents one valuation interval. Historical CAGRs measure performance over considerably longer periods and should be interpreted independently. Fund size, portfolio concentration and expense ratio similarly provide contextual information rather than signals about the direction of subsequent NAV changes. 

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.